Allegiant Travel CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Allegiant Travel CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.61B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.51B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.51B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.30B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.71B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $990.07M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.84B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $1.67B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.51B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.38B | Feb 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.32B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.22B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.32B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.14B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.58B | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | $902.19M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.68B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $1.53B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.37B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.27B | Feb 28, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($44.70M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($240.24M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $117.60M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.49M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $151.85M | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | ($184.09M) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $232.12M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $161.80M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $198.15M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $220.87M | Feb 28, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.17M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($239.98M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $220.98M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $91.65M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $263.08M | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | ($280.99M) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $363.95M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $243.46M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $230.63M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $372.57M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.21B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.43B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $4.86B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $4.51B | Mar 3, 2025 |
| FY2021 | Dec 31, 2021 | $3.99B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $3.26B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $3.01B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.50B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.18B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.67B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.16B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.34B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.53B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $3.29B | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $2.77B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $2.56B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $2.13B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.81B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.63B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.20B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.05B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.33B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $1.22B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $1.22B | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $699.36M | Feb 29, 2024 |
| FY2021 | Dec 31, 2019 | $883.55M | Feb 27, 2023 |
| FY2021 | Dec 31, 2018 | $690.32M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $553.31M | Mar 1, 2021 |
| FY2017 | Dec 31, 2016 | $473.62M | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | (13) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | (11) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 14 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 10 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 12 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 13 | Feb 28, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | (13) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 29, 2024 |
| FY2021 | Dec 31, 2020 | (11) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | 14 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 10 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 12 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 13 | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $172.70M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $285.89M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $143.26M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $229.99M | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $363.38M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $152.76M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $121.89M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $81.52M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $59.45M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $64.71M | Mar 1, 2018 |